علاج نقص مثبط C1 المكتسب مع نوبة حادة ذات أهمية سريرية تستلزم الدخول للمستشفى

References

• Patient with a diagnosis of AAE-C1-INH with a clinically significant attack that requires admission/injected treatment on clinical and risk assessment
• A clinically significant attack as defined by i) potentially life threatening because it affects the head or neck or ii) causes pain or disability such that the patient cannot continue their normal activities.
• Icatibant
• Intravenous C1-esterase inhibitor
• In appropriate cases and where available, licensed recombinant products should be considered in preference to plasma-derived products in the treatment of acute attacks.